Viscosupplementation in patients with osteoarthritis of the knee
- PMID: 23391675
- DOI: 10.3810/pgm.2013.01.2618
Viscosupplementation in patients with osteoarthritis of the knee
Abstract
Osteoarthritis (OA) of the knee is a chronic and progressive disease that is the product of failure of the joint to repair cartilage breakdown and wear. This article reviews the physiologic properties and pathological changes in the synovial fluid that occur in patients with OA. Exogenous hyaluronic acid (HA) has analgesic, chondroprotective, and disease-modifying effects. Viscosupplements of HA are useful in the treatment of OA in conjunction with other methods of conservative treatment. Viscosupplementation may be better tolerated than oral medication, which can have significant side effects and drug interactions. Unlike other OA treatments, viscosupplements do not carry precautions for comorbidities, such as diabetes or cardiovascular disease. A number of HA viscosupplements are available for intra-articular injection in the treatment of knee OA. These supplements vary in molecular weight, dosage per injection, residence time in the joint, and number of injections required for treatment.
Similar articles
-
Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis.Arthroscopy. 2011 Nov;27(11):1490-501. doi: 10.1016/j.arthro.2011.05.011. Epub 2011 Aug 10. Arthroscopy. 2011. PMID: 21831567 Clinical Trial.
-
Use of viscosupplementation for knee osteoarthritis: an update.Curr Sports Med Rep. 2011 Sep-Oct;10(5):279-84. doi: 10.1249/JSR.0b013e31822ed1b4. Curr Sports Med Rep. 2011. PMID: 23531974 Review.
-
Assessment of knee function and biochemical parameters of articular fluid and peripheral blood in gonarthrosis patients following intra-articular administration of hyaluronic acid.Pol Orthop Traumatol. 2013 Aug 16;78:173-81. Pol Orthop Traumatol. 2013. PMID: 23959433 Clinical Trial.
-
Chondroprotective effects of high-molecular-weight cross-linked hyaluronic acid in a rabbit knee osteoarthritis model.Osteoarthritis Cartilage. 2014 Jan;22(1):121-7. doi: 10.1016/j.joca.2013.10.005. Epub 2013 Nov 1. Osteoarthritis Cartilage. 2014. PMID: 24185110
-
Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis.Issues Emerg Health Technol. 2006 Nov;(94):1-4. Issues Emerg Health Technol. 2006. PMID: 17096501 Review.
Cited by
-
Grafting of cationic molecules to hyaluronic acid improves adsorption and cartilage lubrication.Biomater Sci. 2024 Aug 9. doi: 10.1039/d4bm00532e. Online ahead of print. Biomater Sci. 2024. PMID: 39118400 Free PMC article.
-
HPLC-UV Method Validation for Amobarbital and Pharmaceutical Stability Evaluation When Dispersed in a Hyaluronic Acid Hydrogel: A New Concept for Post-Traumatic Osteoarthritis Prevention.J Pharm Sci. 2022 May;111(5):1379-1390. doi: 10.1016/j.xphs.2021.09.025. Epub 2021 Sep 23. J Pharm Sci. 2022. PMID: 34563533 Free PMC article.
-
Effect of Cross-Linked Hyaluronate Scaffold on Cartilage Repair: An In Vivo Study.Orthop Surg. 2019 Aug;11(4):679-689. doi: 10.1111/os.12508. Epub 2019 Aug 5. Orthop Surg. 2019. PMID: 31385411 Free PMC article.
-
[Hyaluronate acid for treatment of chondromalacia patellae: a 52-week follow-up study].Nan Fang Yi Ke Da Xue Xue Bao. 2019 Jul 30;39(7):791-796. doi: 10.12122/j.issn.1673-4254.2019.07.07. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 31340911 Free PMC article. Chinese.
-
Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis.Open Rheumatol J. 2016 Oct 31;10:88-100. doi: 10.2174/1874312901610010088. eCollection 2016. Open Rheumatol J. 2016. PMID: 27867433 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
